UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LB017-MON UPDATE ON PHARMACOECONOMICS IN NUTRITION: PARENTERAL GLUTAMINE SUPPLEMENT IN INTENSIVE CARE UNIT PATIENTS

Clinical nutrition (Edinburgh, Scotland), 2013-09, Vol.32, p.S238-S239

2013

Volltextzugriff (PDF)

An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

Value in health, 2014-11, Vol.17 (7), p.A672-A673

2014

Volltextzugriff (PDF)

Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients

Value in health, 2013-11, Vol.16 (7), p.A371-A371

2013

Volltextzugriff (PDF)

Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

Value in health, 2013-11, Vol.16 (7), p.A385-A386

2013

Volltextzugriff (PDF)

PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

Value in health, 2012-11, Vol.15 (7), p.A350-A350

2012

Volltextzugriff (PDF)

CV3 Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the UK

Value in health, 2012-11, Vol.15 (7), p.A281-A281

2012

Volltextzugriff (PDF)

PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

Value in health, 2012-11, Vol.15 (7), p.A388-A388

2012

Volltextzugriff (PDF)

EE494 Optimizing Treatment of Schizophrenia: Pharmacoeconomic Consequences and Potential for Patient Switching to Long-Acting Injectables

Value in health, 2023-12, Vol.26 (12), p.S146

2023

Volltextzugriff (PDF)

Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis

Clinical and experimental rheumatology, 2010-09, Vol.28 (5), p.722

2010

Volltextzugriff (PDF)

P113 The cost-effectiveness of step down from high dose fluticasone/salmeterol dry powder or suspension formulations in asthma applied to the UK setting

Thorax, 2011-12, Vol.66 (Suppl 4), p.A113-A114

2011

Volltextzugriff (PDF)

EE647 Real-Word Effectiveness and Cost Consequence of Antipsychotic Treatment Choices in the Treatment of Schizophrenia in Italy: A Bayesian Hierarchical Inference Model

Value in health, 2022-12, Vol.25 (12), p.S183-S183

2022

Volltextzugriff (PDF)

PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK Setting

Value in health, 2011, Vol.14 (7), p.A493-A494

2011

Volltextzugriff (PDF)

PIH25 - BE AWARE OF PEDIATRIC MALNUTRITION AT ADMISSION! ECONOMIC CONSEQUENCES OF DIFFERENT HOSPITAL SCREENING AND NUTRITIONAL TREATMENT APPROACHES

Value in health, 2018-10, Vol.21, p.S217-S217

2018

Volltextzugriff (PDF)

PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY

Value in health, 2018-10, Vol.21, p.S45-S45

2018

Volltextzugriff (PDF)

Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

Value in health, 2015-11, Vol.18 (7), p.A765-A765

2015

Volltextzugriff (PDF)

PND95 - Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

Value in health, 2015-11, Vol.18 (7), p.A765-A765

2015

Volltextzugriff (PDF)

PCN147 ENTRECTINIB IN NTRK TUMOR AGNOSTIC INDICATION COMPARED TO DIFFERENT STANDARD OF CARE IN VARIOUS TUMORS TYPES: A COST-EFFECTIVENESS ANALYSIS IN ITALIAN PATIENTS

Value in health, 2019-11, Vol.22, p.S464

2019

Volltextzugriff (PDF)

PCN152 COST-UTILITY AUC MODEL ADAPTED TO ITALIAN CLINICAL PRACTICE FOR EVALUATION OF ENTRECTINIB VERSUS STANDARD OF CARE IN ROS1+ NSCLC PATIENTS

Value in health, 2019-11, Vol.22, p.S465

2019

Volltextzugriff (PDF)

PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?

Value in health, 2011, Vol.14 (7), p.A500-A501

2011

Volltextzugriff (PDF)

PCV66 ECONOMIC PERFORMANCE OF DABIGATRAN ETEXILATE FOR PRIMARY VTE PREVENTION FOLLOWING TOTAL HIP AND KNEE REPLACEMENT SURGERY IN ITALY

Value in health, 2010, Vol.13 (7), p.A353-A353

2010

Volltextzugriff (PDF)

PIN52 - An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

Value in health, 2014-11, Vol.17 (7), p.A672-A673

2014

Volltextzugriff (PDF)

PRS32 - Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients

Value in health, 2013-11, Vol.16 (7), p.A371-A371

2013

Volltextzugriff (PDF)

PSY47 - Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

Value in health, 2013-11, Vol.16 (7), p.A385-A386

2013

Volltextzugriff (PDF)

PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY

Value in health, 2010, Vol.13 (7), p.A305-A305

2010

Volltextzugriff (PDF)

PSY3 CLINICAL AND ECONOMIC OUTCOMES OF ZICONOTIDE NEUROMODULATION IN ITALIAN CANCER PATIENTS

Value in health, 2010, Vol.13 (7), p.A460-A460

2010

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

LB017-MON UPDATE ON PHARMACOECONOMICS IN NUTRITION: PARENTERAL GLUTAMINE SUPPLEMENT IN INTENSIVE CARE UNIT PATIENTS

An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients

Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

CV3 Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the UK

PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

EE494 Optimizing Treatment of Schizophrenia: Pharmacoeconomic Consequences and Potential for Patient Switching to Long-Acting Injectables

Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis

P113 The cost-effectiveness of step down from high dose fluticasone/salmeterol dry powder or suspension formulations in asthma applied to the UK setting

EE647 Real-Word Effectiveness and Cost Consequence of Antipsychotic Treatment Choices in the Treatment of Schizophrenia in Italy: A Bayesian Hierarchical Inference Model

PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK Setting

PIH25 - BE AWARE OF PEDIATRIC MALNUTRITION AT ADMISSION! ECONOMIC CONSEQUENCES OF DIFFERENT HOSPITAL SCREENING AND NUTRITIONAL TREATMENT APPROACHES

PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY

Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

PND95 - Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

PCN147 ENTRECTINIB IN NTRK TUMOR AGNOSTIC INDICATION COMPARED TO DIFFERENT STANDARD OF CARE IN VARIOUS TUMORS TYPES: A COST-EFFECTIVENESS ANALYSIS IN ITALIAN PATIENTS

PCN152 COST-UTILITY AUC MODEL ADAPTED TO ITALIAN CLINICAL PRACTICE FOR EVALUATION OF ENTRECTINIB VERSUS STANDARD OF CARE IN ROS1+ NSCLC PATIENTS

PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?

PCV66 ECONOMIC PERFORMANCE OF DABIGATRAN ETEXILATE FOR PRIMARY VTE PREVENTION FOLLOWING TOTAL HIP AND KNEE REPLACEMENT SURGERY IN ITALY

PIN52 - An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

PRS32 - Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients

PSY47 - Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY

PSY3 CLINICAL AND ECONOMIC OUTCOMES OF ZICONOTIDE NEUROMODULATION IN ITALIAN CANCER PATIENTS

Aktive Filter

Suchergebnisse filtern